Cover Image
市場調查報告書

慢性心臟衰竭:全球臨床實驗檢討

Chronic Heart Failure Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 311767
出版日期 內容資訊 英文 102 Pages
訂單完成後即時交付
價格
Back to Top
慢性心臟衰竭:全球臨床實驗檢討 Chronic Heart Failure Global Clinical Trials Review, H2, 2014
出版日期: 2014年08月30日 內容資訊: 英文 102 Pages
簡介

心臟衰竭是指心臟無法將充足的血液送達其他器官的狀態所造成的。慢性心臟衰竭最常見的原因是由於心臟病發作造成左心室肌肉損傷,瘲狀為強烈的疲勞感、呼吸急促(有時是呼吸困難)、腳踝腫等。

本報告提供慢性心臟衰竭相關臨床研究的最新趨勢相關分析,提供您疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,Phase、階段別的進展,有潛力的贊助商,各企業及研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 慢性心臟衰竭
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲的臨床實驗數量
    • 中南美及非洲的臨床實驗數量

G7各國臨床實驗數量:心臟血管系統臨床實驗數量上,慢性心臟衰竭臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國(新興7個國家)臨床實驗數量:心臟血管系統臨床實驗數量上,慢性心臟衰竭臨床實驗數量所佔的比例

E7各國(新興7個國家)臨床實驗數量:Phase別

E7各國(新興7個國家)臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

試驗指標達成情況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商的各類型臨床實驗數量

有潛力的贊助商

有潛力的藥劑

  • 最新臨床實驗資訊

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Zensun (Shanghai) Sci & Tech Co., Ltd.
    • Bayer AG
    • Orion Oyj
    • Novartis AG
    • Les Laboratoires Servier SAS
    • Zambon Company S.p.A.
    • 武田藥品工業
    • Galenica Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Alfred E. Tiefenbacher (GmbH & Co. KG)
  • 有代表性的大學·研究所的臨床實驗概要
    • Institut de Recherches Internationales Servier
    • Hull and East Yorkshire Hospitals NHS Trust
    • Fuwai Heart Hospital & Cardiovascular Institute
    • St. Marianna University School of Medicine
    • Federico II University
    • University Health Network
    • U.S. Department of Veterans Affairs
    • Duke University
    • Medical University of Silesia
    • 神戶大學

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄

GlobalData's clinical trial report, "Chronic Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Chronic Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chronic Heart Failure
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chronic Heart Failure
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chronic Heart Failure Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Chronic Heart Failure
      • Jul 08, 2014: CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Zensun (Shanghai) Sci & Tech Co., Ltd.
      • Clinical Trial Overview of Zensun (Shanghai) Sci & Tech Co., Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Orion Oyj
      • Clinical Trial Overview of Orion Oyj
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Les Laboratoires Servier SAS
      • Clinical Trial Overview of Les Laboratoires Servier SAS
      • Zambon Company S.p.A.
      • Clinical Trial Overview of Zambon Company S.p.A.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Galenica Ltd.
      • Clinical Trial Overview of Galenica Ltd.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Alfred E. Tiefenbacher (GmbH & Co. KG)
      • Clinical Trial Overview of Alfred E. Tiefenbacher (GmbH & Co. KG)
    • Clinical Trial Overview of Top Institutes / Government
      • Institut de Recherches Internationales Servier
      • Clinical Trial Overview of Institut de Recherches Internationales Servier
      • Hull and East Yorkshire Hospitals NHS Trust
      • Clinical Trial Overview of Hull and East Yorkshire Hospitals NHS Trust
      • Fuwai Heart Hospital & Cardiovascular Institute
      • Clinical Trial Overview of Fuwai Heart Hospital & Cardiovascular Institute
      • St. Marianna University School of Medicine
      • Clinical Trial Overview of St. Marianna University School of Medicine
      • Federico II University
      • Clinical Trial Overview of Federico II University
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Duke University
      • Clinical Trial Overview of Duke University
      • Medical University of Silesia
      • Clinical Trial Overview of Medical University of Silesia
      • Kobe University
      • Clinical Trial Overview of Kobe University
  • Five Key Clinical Trial Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chronic Heart Failure Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Chronic Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Chronic Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Zensun (Shanghai) Sci & Tech Co., Ltd., 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Orion Oyj, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires Servier SAS, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Galenica Ltd., 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfred E. Tiefenbacher (GmbH & Co. KG), 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hull and East Yorkshire Hospitals NHS Trust, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Fuwai Heart Hospital & Cardiovascular Institute, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Marianna University School of Medicine, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014*

List of Figures

  • Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top